| 1 | FASLG, NR5A2
|
| Liver receptor homolog-1 (NR5a2) regulates CD95/Fas ligand transcription and associated T-cell effector functions.
|
| Schwaderer J, Gaiser AK, Phan TS, Delgado ME, Brunner T.
|
| Cell Death Dis 8(4):e2745. doi: 10.1038/cddis.2017.173.
2017
|
| 2 | ADAM10, ADAM17, FASLG
|
| Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytes.
|
| Ebsen H, Lettau M, Kabelitz D, Janssen O.
|
| Mol Immunol 65(2):416-28. doi: 10.1016/j.molimm.2015.02.008. Epub 2015 Mar 5.
2015
|
| 3 | CCL2, FASLG
|
| Monocyte chemoattractant protein-1 (MCP-1) regulates macrophage cytotoxicity in abdominal aortic aneurysm.
|
| Wang Q, Ren J, Morgan S, Liu Z, Dou C, Liu B.
|
| PLoS One 9(3):e92053. doi: 10.1371/journal.pone.0092053. eCollection 2014.
2014
|
| 4 | CA2, FASL, FASLG, OSCAR
|
| The effect of rotative stress on CAII, FAS, FASL, OSCAR, and TRAP gene expression in osteoclasts.
|
| Qing Hong Z, Meng Tao L, Yi Z, Wei L, Ju Xiang S, Li L.
|
| J Cell Biochem 114(2):388-97. doi: 10.1002/jcb.24372.
2013
|
| 5 | FASL, FASLG
|
| FAS mRNA editing in Human Systemic Lupus Erythematosus.
|
| Wu J, Xie F, Qian K, Gibson AW, Edberg JC, Kimberly RP.
|
| Hum Mutat 32(11):1268-77. doi: 10.1002/humu.21565. Epub 2011 Aug 11.
2011
|
| 6 | FAS, FASLG
|
| CD95 promotes tumour growth.
|
| Chen L, Park SM, Tumanov AV, Hau A, Sawada K, Feig C, Turner JR, Fu YX, Romero IL, Lengyel E, Peter ME.
|
| Nature 465(7297):492-6.PMID: 20505730 2010
|
| 7 | FAS, FASLG
|
| A non-apoptotic role for Fas/FasL in erythropoiesis.
|
| Carlile GW, Smith DH, Wiedmann M.
|
| FEBS Lett 583(4):848-54. 2009
|
| 8 | FASLG, THY1
|
| Thy1 up-regulates FasL expression in lung myofibroblasts via Src family kinases.
|
| Cohen PY, Breuer R, Wallach-Dayan SB.
|
| Am J Respir Cell Mol Biol 40(2):231-8. Epub 2008 Aug 1.
2009
|
| 9 | FASLG, GRB2
|
| The adaptor protein Grb2 regulates cell surface Fas ligand in Schwann cells.
|
| Thornhill PB, Cohn JB, Stanford WL, Desbarats J.
|
| Biochem Biophys Res Commun 376(2):341-6. Epub 2008 Sep 16.
2008
|
| 10 | FAS, FASL, FASLG
|
| CD95 stimulation results in the formation of a novel death effector domain protein-containing complex.
|
| Lavrik IN, Mock T, Golks A, Hoffmann JC, Baumann S, Krammer PH.
|
| J Biol Chem 283(39):26401-8. Epub 2008 Jul 17. 2008
|
| 11 | ADAM10,FASLG
|
| ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death.
|
| Schulte M, Reiss K, Lettau M, Maretzky T, Ludwig A, Hartmann D, de Strooper B, Janssen O, Saftig P.
|
| Cell Death Differ 14(5):1040-9. Epub 2007 Feb 9. 2007
|
| 12 | ADAM10, FASLG
|
| ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death.
|
| Schulte M, Reiss K, Lettau M, Maretzky T, Ludwig A, Hartmann D, de Strooper B, Janssen O, Saftig P.
|
| Cell Death Differ 14(5):1040-9. Epub 2007 Feb 9.
2007
|
| 13 | FASLG
|
| Analysis of fas ligand gene mutation in patients with systemic lupus erythematosus.
|
| Kojima T, Horiuchi T, Nishizaka H, Sawabe T, Higuchi M, Harashima SI, Yoshizawa S, Tsukamoto H, Nagasawa K, Niho Y.
|
| Arthritis Rheum 43(1):135-9. 2000
|
| 14 | FAS, FASLG
|
| Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations.
|
| Siegel RM, Frederiksen JK, Zacharias DA, Chan FK, Johnson M, Lynch D, Tsien RY, Lenardo MJ.
|
| Science 288(5475):2354-7. 2000
|
| 15 | FASLG, FAS
|
| FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier.
|
| Bechmann I, et al.
|
| Glia 27(1):62-74 1999
|
| 16 | FASLG
|
| Fas ligand: a sensor for DNA damage critical in skin cancer etiology.
|
| Hill LL, et al.
|
| Science 285(5429):898-900 1999
|
| 17 | FASLG, FASLG, LTA
|
| Downregulation of fas ligand by shedding.
|
| Tanaka M, Itai T, Adachi M, Nagata S.
|
| Nat Med 4(1):31-6. 1998
|
| 18 | FASLG, CSS2
|
| Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.
|
| Wu J, et al.
|
| J Clin Invest 98(5):1107-13. 1996
|
| 19 | PHLDA1, FASLG, FAS
|
| A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death.
|
| Park CG, Lee SY, Kandala G, Lee SY, Choi Y.
|
| Immunity 4(6):583-91. 1996
|
| 20 | FASLG
|
| Multiple pathways originate at the Fas/APO-1 (CD95) receptor : sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal.
|
| Cifone MG, Roncaioli P, De Maria R, Camarda G, Santoni A, Ruberti G, Testi R.
|
| EMBO J 14 : 5859-5868. 1995
|
| 21 | FASLG
|
| Human fas ligand : gene structure, chromosomal location and species specificity.
|
| Takahashi T, et al.
|
| Int Immunol 6 : 1567-1574. 1994
|